L. Buck and Howard P. Goodkin
The unique mechanism of action of lacosamide, as well as a lack of significant drug interactions, a relatively mild adverse effect profile, and the availability of both…
The unique mechanism of action of lacosamide, as well as a lack of significant drug interactions, a relatively mild adverse effect profile, and the availability of both…
Epilepsy is suspected when there is repetition of seizures or an unprovoked seizure is accompanied by a probability of further seizures similar to the general recurrence risk…
Sleep and epilepsy are interrelated; worsening of one leads to worsening of the other and a vicious cycle starts. Sleep activates interictal epileptiform discharges (IEDs) and seizures….
The first 4 weeks of life represent one of the greatest periods of seizure hazard during childhood. The occurrence of seizures within this neonatal period is associated…
For a long time, neonatal seizures and focal epilepsies in infancy have been viewed with suspicion for a probable association with brain lesions. Now, it is well…
The familial focal epilepsies with onset in childhood or adolescence are classified according to the focus of seizure onset in different members of the same family. Seizure…
When rufinamide received its approval from the U.S. Food and Drug Administration (FDA) in November 2008, it was the first time that a new anticonvulsant medication was…
ETHOSUXIMIDE Ethosuximide (ESM) is a succinimide antiepileptic drug in clinical use since 1958 for a limited spectrum of seizure types, chiefly absence seizures, for which it remains…
INTRODUCTION There are many inborn errors of metabolism (IEMs) that cause disease in humans, and hundreds of these can produce encephalopathy and seizures. In fact, we now…
INTRODUCTION The International Classification of Epilepsies and Epileptic Syndromes (1) divides epilepsy, first, on the basis of whether the seizures are focal (localization-related epilepsies), generalized (originating at…